OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Papilloedema reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,475 reports · 129 co-occurring drugs

As of the last recalculation, Papilloedema appears in 4,475 FAERS reports alongside 129 co-occurring drug terms. The strongest observed disproportionality signal is MINOCYCLINE (PRR 21.8).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Minocycline5421.821.9
Tretinoin2413.813.9
Elexacaftor, Tezacaftor, And Ivacaftor3312.412.4
Testosterone5310.710.7
Levonorgestrel3398.48.4
Ivacaftor148.28.2
Pyrazinamide157.47.5
Somatropin1117.27.2
Goserelin196.66.6
Prednisolone Acetate146.36.3
Dabrafenib286.26.2
Amphotericin B166.06.0
Pertuzumab335.75.7
Trametinib285.45.4
Anastrozole Tablets245.25.2
Isoniazid185.25.2
Doxycycline Hyclate745.25.2
Doxycycline745.15.1
Rifampicin115.15.1
Brentuximab Vedotin115.05.0
Human Immunoglobulin G225.05.0
Canakinumab114.74.7
Carboplatin1254.74.7
Melphalan Hydrochloride254.74.7
Vemurafenib124.74.7
Ifosfamide214.64.6
Melphalan224.54.5
Mycophenilic Acid204.54.5
Imatinib174.54.5
Blinatumomab104.54.5
Cytarabine574.54.5
Mycophenolic Acid304.44.4
Efavirenz104.24.2
Testosterone Cypionate84.24.2
Sirolimus124.24.2
Adalimumab-Fkjp414.14.1
Trastuzumab604.14.1
Lamivudine Oral224.14.1
Dutasteride74.04.0
Mesna Injection73.93.9
Lamivudine263.93.9
Docetaxel Anhydrous563.93.9
Docetaxel563.93.9
Mesna73.93.9
Abacavir Sulfate83.83.8
Drospirenone And Ethinyl Estradiol363.83.8
Etonogestrel And Ethinyl Estradiol183.83.8
Linezolid243.83.8
Adalimumab-Aaty383.83.8
Romiplostim123.73.7
Cyclosporine873.73.7
Ipilimumab343.73.7
Oxaliplatin583.73.7
Dronedarone83.73.7
Bosutinib73.63.6
Anastrozole283.63.6
Zidovudine103.53.5
Etoposide543.43.4
Fluorouracil Cream, 0.5%553.43.4
Adalimumab-Adaz383.43.4
Imatinib Mesylate203.33.3
Fluorouracil553.33.3
Amiodarone Hydrochloride83.33.3
Isotretinoin353.33.3
Crizotinib93.33.3
Erythropoietin143.23.2
Nilotinib203.23.2
Siponimod63.13.1
Nevirapine63.13.1
Voriconazole203.13.1
Tacrolimus Ointment 0.1%813.13.1
Bicalutamide103.13.1
Tacrolimus Extended-Release Capsules813.13.1
Fosaprepitant Dimeglumine93.03.0
Acetaminophen, Aspirin (Nsaid) And Caffeine113.03.0
Doxyclycline Hyclate113.03.0
Nivolumab613.03.0
Thiotepa62.92.9
Vincristine Sulfate182.92.9
Ceftriaxone202.82.8
Cyclophosphamide Injection, Solution1062.82.8
Cyclophosphamide1062.82.8
Cyclophosphamide For Injection1062.82.8
Darunavir92.82.8
Naproxen Sodium Tablet, Coated82.82.8
Naproxen Sodium, Coated Tablets82.82.8
Naproxen Sodium 220Mg82.72.7
Bleomycin Sulfate62.72.7
Ceftriaxone Sodium222.72.7
Pembrolizumab602.72.7
Thalidomide212.72.7
Acetaminophen, Aspirin, And Caffeine122.72.7
Aflibercept172.52.5
Aprepitant102.52.5
Letrozole Tablets262.52.5
Paclitaxel (Aibumin-Bound)442.52.5
Cisplatin412.52.5
Panitumumab82.42.4
Dornase Alfa102.42.4
Pemetrexed Disodium192.32.3
Paclitaxel492.32.3
Bortezomib442.32.3
Sildenafil Citrate622.32.3
Ixazomib142.32.3
Etonogestrel222.12.2
Oral Semaglutide332.12.1
Eltrombopag Olamine102.02.0
Dasatinib162.02.0
Atomoxetine Hydrochloride102.02.0
Pemetrexed92.02.0
Gemcitabine161.91.9
Doxorubicin361.91.9
Axicabtagene Ciloleucel41.91.9
Ribavirin261.91.9
Asfotase Alfa41.91.9
Gemcitabine Hydrochloride211.81.8
Faricimab31.71.7
Carfilzomib101.61.6
Fingolimod Hcl301.61.6
Peginterferon Alfa-2A181.61.6
Encorafenib31.41.4
Ranibizumab81.41.4
Abemaciclib61.41.4
Remdesivir41.41.4
Durvalumab61.41.4
Medroxyprogesterone Acetate141.31.3
Vigabatrin41.31.3
Erenumab-Aooe100.80.8
Adapalene60.20.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.